Mission / Vision / Values
Bringing the microbiome to the heart of healthcare
Detect, transpose and make available microbiome-based innovations addressing global public health issues
Know-how; Human relationships; Scientific rigor
Grégory LAMBERT CEO
Clémentine TROTIN- PICOLO Technical Director
Nina VINOT Sales & Marketing Director
Laetitia VIGNANE Office & Supply Manager
Arnaud FAURE Marketing manager
Joséphine GEHRING Project Manager
Pierre DÉCHELOTTE Founder, Medical referent
Sergueï FETISSOV Founder, Medical referent
Franck ALBERT Sales Manager France
Joséphine GORRON Dietician Nutritionist
Laurent NOBILÉ QA Manager
Christine VIGNE- BIMAI HR Manager
Luc MALACHANE CFO
CEO and VP R&D
Grégory LAMBERT’s career has been split between biotech and pharmaceutical companies, in roles such as VP of R&D and General Manager of Novagali Pharma (now Santen) and CSO at Septodont. His responsibilities covered management of IP and business development activities, innovation and CMC as well as pre-clinical and clinical development in Europe and North America. Gregory is an inventor on more than 20 patents, he was involved in the IPO of Novagali Pharma and he drove the development of several pharmaceutical products from the laboratory to market authorizations. In 2014, Gregory joined the scientific founders of TargEDys as CEO to setup the business plan and start operations.
Chairman of the Board
Philippe LAVIELLE is an accomplished entrepreneur. He is currently Chairman and CEO of Fermentalg, a French industrial biotech company specializing in microalgae derived products. Until July 2014 Philippe was President and CEO of Virdia Inc., a biotech company producing carbohydrates from cellulosic biomass. His teams developed one of the world’s most advanced ligno-cellulosic bio-refinery platforms. Prior to joining Virdia, Philippe was Executive Vice President of Genencor Inc., the US based world leader in industrial biotechnology in renewable fuels and bio-chemicals. Philippe is also a Board member of Clara Foods Inc., a US company working towards creating the world’s first animal-free egg white.
Danilo Casadei- Massari
Independant Board Member
Danilo has extensive experience as a senior pharmaceutical executive and as a highly successful serial entrepreneur. Most recently he was a founder and President of CM&D Pharma Ltd, a medical foods company he founded in 2007 and sold to Nestle Health Science in 2011. He is currently a Director on the boards of companies based in the USA, Italy, Ireland, Finland and France as well as a Cofounder in some of them. Danilo is an expert in start-ups and co-ventures in the pharmaceutical sector.
Isabelle de Crémoux
President & CEO, Seventure Partners
Isabelle is President and CEO of Seventure Partners and manages the Life Sciences team. She brings 25 years of international experience in life sciences business development and finance. Isabelle makes direct investments, mainly in France and Scandinavia and in the US/Canada with a focus on biotech, nutrition, personalized medicine and especially microbiome. Isabelle’s track record includes Santaris (sold to Roche for $450 millions in august 2014), Argenx (listed), OPI pharma (sold to Eusa for Euro 110 millions), Bioalliance (listed), Pixium Vision (listed), as well as Enterome Bioscience, Maat Pharma and TargEDys.
Nora is Venture Partner with Seventure Partners, a Paris-based venture investor investing broadly in life sciences, with a specific focus on the human microbiome. Nora brings more than 20 years of professional experience in healthcare research, investment, management, strategy and business development. She co-founded several companies and was a board member and chairman of firms in different fields including biotech, nutraceuticals/food production and financial/investment. Nora trained as a microbiologist and biochemist with a PhD focused on immunology at the Biocenter, University of Basel, Switzerland.
VP Business Development, Biocodex
Bernard has an international extensive background as pharmaceutical executive, as countries CEO (Netherlands, Portugal, Italy) then European executive positions at Servier and Recordati with significant business and market access achievements in UE Top 5. He holds a Ph.D in Pharmacy and a MBA from HEC, has a real passion for Life Sciences and supports various innovative Medtech start-ups as Business Angel.
Investment analyst, NCI
Laurie is an investment analyst at NCI, a Normandy -based structure which invests in companies operating in Normandy and in Paris. NCI accompanied more than 130 firms at different stages (VC, LBO, growth capital) and in diverse industries. With a double-digit growth track record, and €180M in managed assets (entrusted by public and private institutional investors), NCI conciliates finance and economic development. Laurie graduated from Rouen Business School in Corporate Finance and passed all the three levels of the CFA Program.
Independant Board Member
Eric has extensive international commercial experience in Pharma (orphan and specialty drugs, health care products and services) and Nutrition (especially microbiome). Eric holds a Ph.D in Pharmacy and assumed senior leadership roles with proven-track record amongst international firms such as Actelion, Sanofi and Danone. In particular at Actelion, he built and grew the commercial teams across Europe, Russia/CIS and Latin America, then successfully handled the full integration of Actelion into Janssen. Currently he undertakes consulting assignments and manages board member positions. His passion: Support SME in Pharma/Biotech/Nutrition and create value for patients with unmet medical needs across the world.